You searched for Humanized antibody - Page 34 of 45

In Depth 19 Jan 2022

Glycans Hit the Sweet Spot in Diagnostics

…the glycosylation patterns of antibodies reveals much more insights into disease progression than just looking at antibody levels. For instance, while the levels of a type of antibody known as…

January 19, 2022 - 5 minutesmins - By Sachin Rawat

News and Trends 23 Mar 2023

OncoC4 and BioNTech partner in the commercialization of cancer drug candidate

…ONC-392, which is an anti-CTLA-4 monoclonal antibody, is in phase 1/2 trial, following the U.S. Food and Drug Administration’s (FDA) nod for Fast Track designation for immunotherapy-resistant non-small cell lung…

March 23, 2023 - 2 minutesmins - By Roohi Mariam Peter

immutep checkpoint inhibitor lag 3 cancer

Interview 29 Nov 2022

LAG-3: The next big checkpoint inhibitor target

…is ripe for innovation in the space. Immune checkpoint inhibitors have revolutionized the field of immuno-oncology in the last decade, especially since the approval of the antibody drug ipilimumab (Yervoy)…

November 29, 2022 - 7 minutesmins - By Jonathan Smith

genentech immunocore immunotherapy pipette

News and Trends 20 Nov 2018

Genentech and Immunocore Expand Partnership to Develop Cancer Immunotherapy

…a fusion protein that combines engineered T cell proteins with antibody fragments. One end of the fusion protein binds with specific antigens on the surface of tumor cells, whereas the…

November 20, 2018 - 2 minutesmins - By Jonathan Smith

More News! 3 Jul 2018

NASA Studies How Outer Space Affects the Immune System

NASA is using an antibody assay to investigate the effect of space flight on white blood cells in astronauts on the International Space Station. The assay used by NASA measures…

July 3, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 22 Jun 2020

Swedish Biotech’s Psoriasis Drug Beats Placebo in Phase II

…the market such as Humira and Cosentyx, these antibody drugs aren’t well suited to subcutaneous injections because they can’t penetrate subcutaneous tissue well. Affibody’s psoriasis candidate is a protein drug…

June 22, 2020 - 3 minutesmins - By David Wilson

Best in Biotech 13 May 2025

Nine biotech companies in Montreal to keep an eye on in 2025

…funding round in 2024 Situated in Montreal, Ability Biotherapeutics has come up with its discovery engine AbiLeap that combines AI and a database of antigen-antibody interactions in order to develop…

May 13, 2025 - 11 minutesmins - By Roohi Mariam Peter

liver fibrosis alentis switzerland cirrhosis cancer

News and Trends 30 Apr 2019

Swiss Biotech Raises €11M to Develop Treatments for Liver Fibrosis

Founded in March this year, Alentis Therapeutics has bagged a Series A round of €11.1M (CHF 12.5M) to develop antibody drugs treating liver fibrosis, which currently has no approved treatments….

April 30, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 1 Mar 2017

Swedish Oncology Biotech makes a Large IPO for its Peptides

…Squibb and is the first antibody therapy against multiple myeloma and was approved in May 2016. Moreover, Janssen’s anti-CD38 antibody daratumumab reached its primary endpoint in the first Phase III…

March 1, 2017 - 3 minutesmins - By Melanie De Almeida

News and Trends 6 Jan 2023

Transgene approved for IV oncolytic virus trial

…powerful antitumor immune response, and a full length anti-CTLA4 antibody. By selectively targeting tumor cells and expressing IL-12 and the anti-CTLA4 antibody in the tumor microenvironment, TG6050 is expected to…

January 6, 2023 - 3 minutesmins - By Jim Cornall

bicycle therapeutics solid tumors trial 1

News and Trends 14 Feb 2018

Bicycle’s First Peptide-Toxin Conjugate Enters the Clinic for Solid Tumors

…tumors that express high levels of a molecule called Membrane Type 1 Matrix Metalloproteinase (MT1-MMP). The technology was developed by Greg Winter, who founded Cambridge Antibody Technology, which discovered the…

February 14, 2018 - 3 minutesmins - By Alex Dale

In Depth 22 Dec 2022

10 biotech companies to watch in 2023

…Headquarters: Netherlands As biotech stock markets continued to stagnate in 2022, Argenx was one of the few biotech companies whose stock price increased. The company’s lead drug is an antibody…

December 22, 2022 - 9 minutesmins - By Jonathan Smith

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Humanized antibody

Glycans Hit the Sweet Spot in Diagnostics

OncoC4 and BioNTech partner in the commercialization of cancer drug candidate

LAG-3: The next big checkpoint inhibitor target

Genentech and Immunocore Expand Partnership to Develop Cancer Immunotherapy

NASA Studies How Outer Space Affects the Immune System

Swedish Biotech’s Psoriasis Drug Beats Placebo in Phase II

Nine biotech companies in Montreal to keep an eye on in 2025

Swiss Biotech Raises €11M to Develop Treatments for Liver Fibrosis

Swedish Oncology Biotech makes a Large IPO for its Peptides

Transgene approved for IV oncolytic virus trial

Bicycle’s First Peptide-Toxin Conjugate Enters the Clinic for Solid Tumors

10 biotech companies to watch in 2023

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!